aMoon
aMoon

aMoon

2016Venture Capital22 portfolio$1.3B AUMIsrael

About

aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare.Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives.We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality.Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.

Key facts

At-a-glance profile data

Website
amoon.fund
Type
Venture Capital
Headquarters
Israel
Funds raised
$1.3B
Portfolio companies
22
Stages
Seed
Series A
Series B
Series C
Cheque size
$10M to $50M
Sector focus
Life Sciences
Cancer
Therapeutics
Biotech
Personalized Treatment

Recent investments

Recent funding rounds aMoon took part in
DateCompanyRoundAmount
28 Jan 2025Lutris PharmaSeries A$30M
1 Oct 2024Air DoctorSeries B$20M
1 Jun 2024Cavos BiotechSeedUndisclosed
8 Nov 2023Eleos HealthSeries B$40M
6 Sept 2023Ibex Medical AnalyticsSeries C$55M
30 Nov 2022Nectin TherapeuticsSeries B$25M
5 Apr 2022Eleos HealthSeries A$20M
13 Sept 2021Eleos HealthSeed$6M
31 May 2021DayTwoSeries C$37M
9 Mar 2021Ibex Medical AnalyticsSeries B$38M
Add first review

Frequently asked

What companies has aMoon invested in?

aMoon has invested in Lutris Pharma, Air Doctor, Cavos Biotech, Eleos Health, Ibex Medical Analytics and 17 more.